comlogo1.svg

Your privacy is very important for us. When you visit our website, please agree to the use of all cookies. For more information about the processing of personal data, please go to Privacy and Information Security

July 01, 2026

Xunfei Healthcare Partners with Sinar Mas to Expand AI Healthcare Across Southeast Asia

Recently, Xunfei Healthcare (02506.HK) issued a voluntary announcement, stating that it has entered into an in-depth strategic partnership with PT DSST Mas Gemilang, a digital-intelligent infrastructure and technology investment platform under Indonesia’s Sinar Mas Group. Focusing on core areas of AI-powered healthcare, the two parties will integrate their strengths in technology, channels, infrastructure, and localized operations to jointly accelerate the digital and intelligent transformation of healthcare across Indonesia and Southeast Asia, support the high-quality development of local public health systems, and deliver a key milestone in Xunfei Healthcare’s efforts to deepen its presence in overseas markets and advance practical cooperation in digital-intelligent healthcare under the Belt and Road Initiative.


Targeting Southeast Asia’s Blue Ocean Market, Building a Strong Foundation for Government-Enterprise Cooperation


With a population of 680 million, Southeast Asia offers not only a vast demographic base and strong development potential, but also one of the world’s fastest-growing demands for digital and intelligent healthcare. Significant market gaps and growing needs for healthcare upgrading have created broad opportunities for the large-scale deployment of mature AI healthcare technologies.


The strategic partnership is the result of deep engagement and long-standing mutual trust between the two parties. Previously, Indonesia’s Vice Minister of Health led a delegation on a dedicated visit to Xunfei Healthcare’s headquarters, where the parties held in-depth discussions on key areas including intelligent assisted diagnosis and treatment at the primary care level, infectious disease monitoring and early warning, and the digital and intelligent upgrading of public health. The visit led to multiple areas of consensus, laying a solid foundation for government-enterprise collaboration ahead of the signing and future full-scale business rollout. The cooperation framework is also closely aligned with Indonesia’s overall public health development plan.


Driving Localized Implementation Through Advanced Technologies and an Innovative Joint Operating Model


With years of experience in China’s AI healthcare sector, Xunfei Healthcare has developed a full-stack medical AI technology platform and built a strong track record in bringing digital healthcare solutions to scale. Its products and solutions now cover more than 77,000 primary healthcare institutions and serve over 600 graded hospitals across China. Tested and refined in a wide range of real-world clinical settings, these solutions are highly deployable and operationally stable.


The partnership introduces a collaborative model that combines technology enablement with local ecosystem operations. Xunfei Healthcare will contribute its proven full-stack AI healthcare technologies, core intellectual property, standardized solutions, and implementation expertise. Its Indonesian partner will bring local government and enterprise networks, digital infrastructure, and end-to-end operational support on the ground. By combining these complementary strengths, the two parties aim to accelerate the localization and large-scale rollout of AI healthcare applications in Indonesia.


Expanding Across the Full Healthcare Continuum and Accelerating Growth Across ASEAN


Under the agreement, the partnership will span Indonesia’s healthcare system, from primary care institutions to national public health platforms. The two parties will focus on high-value applications including AI systems that support the full cycle of disease diagnosis and treatment, national public health surveillance and early-warning systems, intelligent medical imaging, remote radiology services, and digital upgrades for healthcare institutions at all levels. These areas align closely with Xunfei Healthcare’s existing core product portfolio, enabling strong technology reuse and manageable expansion costs.


Building on its self-developed AI healthcare technologies and digital healthcare solutions proven at scale in China, Xunfei Healthcare will support Indonesia in improving the quality, efficiency, and capacity of its public health system. The company will also use Indonesia as a key strategic base for expanding across ASEAN, further strengthening its digital health presence in Southeast Asia, sharing proven smart healthcare practices, and contributing to the intelligent transformation of healthcare worldwide.